MX9206335A - EX VIVO TISSUE DIFFUSION COMPOSITION FOR THE DIFFUSION OF TISSUES AND ORGANS. - Google Patents

EX VIVO TISSUE DIFFUSION COMPOSITION FOR THE DIFFUSION OF TISSUES AND ORGANS.

Info

Publication number
MX9206335A
MX9206335A MX9206335A MX9206335A MX9206335A MX 9206335 A MX9206335 A MX 9206335A MX 9206335 A MX9206335 A MX 9206335A MX 9206335 A MX9206335 A MX 9206335A MX 9206335 A MX9206335 A MX 9206335A
Authority
MX
Mexico
Prior art keywords
diffusion
organs
tissues
vivo tissue
composition
Prior art date
Application number
MX9206335A
Other languages
Spanish (es)
Inventor
Robert L Hunter
Alexander Duncan
Original Assignee
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Emory filed Critical Univ Emory
Publication of MX9206335A publication Critical patent/MX9206335A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una composición efectiva para disolver coágulos en la sangre y re-establecer y mantener el flujo de sangre a través de la coronaria con trombosis u otros vasos sanguíneas.The present invention relates to an effective composition for dissolving blood clots and re-establishing and maintaining blood flow through the coronary with thrombosis or other blood vessels.

MX9206335A 1986-05-15 1992-11-04 EX VIVO TISSUE DIFFUSION COMPOSITION FOR THE DIFFUSION OF TISSUES AND ORGANS. MX9206335A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86358286A 1986-05-15 1986-05-15

Publications (1)

Publication Number Publication Date
MX9206335A true MX9206335A (en) 1994-05-31

Family

ID=25341340

Family Applications (2)

Application Number Title Priority Date Filing Date
MX9206336A MX9206336A (en) 1986-05-15 1992-11-04 METHOD FOR PRESERVATION OF AN EX LIVING ORGAN.
MX9206335A MX9206335A (en) 1986-05-15 1992-11-04 EX VIVO TISSUE DIFFUSION COMPOSITION FOR THE DIFFUSION OF TISSUES AND ORGANS.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX9206336A MX9206336A (en) 1986-05-15 1992-11-04 METHOD FOR PRESERVATION OF AN EX LIVING ORGAN.

Country Status (4)

Country Link
AU (1) AU6334586A (en)
MX (2) MX9206336A (en)
WO (1) WO1987006831A1 (en)
ZA (1) ZA873512B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE59895B1 (en) * 1986-05-12 1994-04-20 Wellcome Found Medicaments containing tissue plasminogen activator
US5648071A (en) * 1986-05-15 1997-07-15 Emory University Method of treating tumors
US4879109A (en) * 1986-05-15 1989-11-07 Emory University Method for treating burns
US5039520A (en) * 1986-05-15 1991-08-13 Emory University Plasma extender
US5811088A (en) * 1987-02-20 1998-09-22 Emory University Antiinfective compounds and methods of use
US5696298A (en) * 1991-03-19 1997-12-09 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
US6933286B2 (en) 1991-03-19 2005-08-23 R. Martin Emanuele Therapeutic delivery compositions and methods of use thereof
WO1992016484A1 (en) * 1991-03-19 1992-10-01 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
USRE38558E1 (en) 1991-03-19 2004-07-20 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
US7202225B1 (en) 1993-10-15 2007-04-10 Emanuele R Martin Therapeutic delivery compositions and methods of use thereof
US5470568A (en) * 1992-02-13 1995-11-28 Arch Development Corporation Methods and compositions of a polymer (poloxamer) for cell repair
US5605687A (en) * 1992-05-15 1997-02-25 Arch Development Corporation Methods and compositions of a polymer (poloxamer) for repair of electrical injury
DK0723440T3 (en) * 1993-10-15 2003-02-24 Cytrx Corp Therapeutic delivery compositions and methods for using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3541240A (en) * 1968-05-22 1970-11-17 Rca Corp Automatic beam current limiting using reference current sources
JPS545094B1 (en) * 1969-06-27 1979-03-13
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4305922A (en) * 1978-10-04 1981-12-15 University Patents, Inc. Labeling proteins with 99m-Tc by ligand exchange
DE3380726D1 (en) * 1982-06-24 1989-11-23 Japan Chem Res Long-acting composition
SU1183112A1 (en) * 1983-08-04 1985-10-07 Научно-Исследовательский Институт Экспериментальной И Клинической Терапии Министерства Здравоохранения Гсср Method of treatment of acute myocardial ischemia
US4600652A (en) * 1985-04-01 1986-07-15 Warner-Lambert Company Permanently bonded antithrombogenic polyurethane surface

Also Published As

Publication number Publication date
ZA873512B (en) 1988-12-28
MX9206336A (en) 1994-05-31
WO1987006831A1 (en) 1987-11-19
AU6334586A (en) 1987-12-01

Similar Documents

Publication Publication Date Title
MX9206335A (en) EX VIVO TISSUE DIFFUSION COMPOSITION FOR THE DIFFUSION OF TISSUES AND ORGANS.
EA199600103A1 (en) Gene transfer-mediated angiogenesis therapy
DE69010840D1 (en) Sterile surgical needle sutures composition.
BR9814491A (en) Heart valve bioprosthesis without stent, and, processes for total root replacement of an endogenous aortic heart valve in a mammalian patient, and for surgical replacement of a heart valve and an adjacent vascular tissue segment in a mammalian patient
IT8467249A0 (en) CARDIAC VALVE PROSTHESIS PROVIDED WITH BIOLOGICAL TISSUE VALVE LEPS
DE69008423D1 (en) Dynamic fixation of porcine acid valves.
FI946004A0 (en) Thrombin blood fraction used in a medical procedure
ATE180976T1 (en) INSIZABLE LECITHIN GEL
IT1210364B (en) SURGICAL SCALPEL OF THE ULTRASONIC CRYOGENIC TYPE.
ATE395418T1 (en) ALPHA(1,3)GALACTOSYLTRANSFERASE NEGATIVE PIG
DK0590015T3 (en) A tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer
NO970748D0 (en) Compounds, pharmaceutical composition and diagnostic device comprising the same and their device
DE68909902D1 (en) Blood treatment device of the hollow fiber type.
FR2591485B1 (en) STABILIZED COMPOSITIONS CONTAINING THE ACTIVATOR OF HUMAN TISSUE PLASMINOGEN.
SE8903583D0 (en) CYCLOSPORIN OPHTHALMIC COMPOSITIONS
ES2039709T3 (en) A PROCEDURE FOR PREPARING AN ANTICOAGULATING COMPOSITION.
AR022482A1 (en) METHODS AND COMPOSITIONS TO USE IN PERFUSION APPLICATIONS
SE8800176L (en) ANTI-INFLAMMATORALLY OXIDATING AGENTS, PROCEDURES FOR PREPARING THEREOF, AND APPLICATION THEREOF
DK0383417T3 (en) Flag salivary plasminogen activator v-PAalfa1
NO871883L (en) PROCEDURE FOR CLEANING THE SINGLE AND DOUBLE-CHAIN TISSUE PLASMINOGEN ACTIVATOR.
PE92298A1 (en) APROTININ VARIANTS WITH IMPROVED PROPERTIES
ES2042529T3 (en) A PROCEDURE FOR PREPARING A COMBINED THERAPEUTIC COMPOSITION OF A FREE RADICALS REMOVAL OR METABOLIC INHIBITOR AND A BIOLOGICALLY ACTIVE PROTEIN.
ES486698A0 (en) IMPROVEMENTS INTRODUCED IN THE MANUFACTURE OF SURGICAL SUTURES ELASTOMERICAS
FR2485928B1 (en) ARTIFICIAL ORGANS TO ASSIST BLOOD CIRCULATION, ESPECIALLY HEART PUMPS AND VALVES
ATE222501T1 (en) TISSUE FACTOR INFLUENCING VASCULAR FORMATION